CUAMC
OKUR

China Universal Asset Management Company’s OnKure Therapeutics OKUR Stock Holding History

China Universal Asset Management Company’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,251
Closed -$6.19K – 542
2025
Q3 		$6.19K Sell
2,251
-325
-13% -$805 ﹤0.01% 473
2025
Q2 		$6.16K Buy
2,576
+38
+1% +$100 ﹤0.01% 472
2025
Q1 		$10.9K Sell
2,538
-145
-5% -$815 ﹤0.01% 476
2024
Q4 		$23.1K Buy
2,683
+2,040
+317% +$30.9K ﹤0.01% 481
2024
Q3 		$10.9K Buy
643
+250
+64% +$3.7K ﹤0.01% 415
2024
Q2 		$5.93K Sell
393
-246
-38% -$4.17K ﹤0.01% 406
2024
Q1 		$10.6K Buy
639
+253
+66% +$4.17K ﹤0.01% 432
2023
Q4 		$6.17K Buy
+386
New +$24.1K ﹤0.01% 417

Other funds holding OKUR

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

China Universal Asset Management Company's OKUR Position: Q4 2025 in Review

China Universal Asset Management Company sold out of OnKure Therapeutics (OKUR) in Q4 2025, closing a stake of 2,251 shares — an estimated $6.19K sold.

China Universal Asset Management Company first reported a position in OKUR in Q4 2023 and held it in 8 quarters. The position peaked at $23.1K in Q4 2024. 44 funds tracked by Wall St. Rank hold OKUR as of Q4 2025.

  • China Universal Asset Management Company reported no remaining OnKure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 2,251 OnKure Therapeutics shares in Q4 2025, an estimated $6.19K.
  • China Universal Asset Management Company first reported a position in OnKure Therapeutics in Q4 2023 and held it in 8 quarters.
  • China Universal Asset Management Company's OnKure Therapeutics position peaked at $23.1K in Q4 2024.
  • 44 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.